CVIR Endovascular is a pioneering journal published by SPRINGERNATURE, dedicated to advancing the fields of cardiology, cardiovascular medicine, and radiology. Established as an Open Access platform since 2018, this journal has become increasingly pivotal for disseminating high-quality research that bridges clinical practice and innovative imaging techniques. With a robust focus on minimally invasive therapies and advancements in endovascular procedures, CVIR Endovascular serves as an essential resource for researchers, professionals, and students alike. The journal is indexed in key databases and holds notable rankings within its categories, specifically achieving Q3 quartile status in both Cardiology and Cardiovascular Medicine and Radiology for 2023. This positions it as an influential publication in the ever-evolving landscape of cardiovascular research. As it converges through the years from 2018 to 2024, CVIR Endovascular continues to strive for excellence, aiming to provide a platform for innovative findings and best practices that can enhance the future of endovascular care.

ANGIOLOGY is a leading journal dedicated to the field of cardiology and cardiovascular medicine, published by SAGE Publications Inc. With a distinguished history dating back to 1950, this journal serves as an essential platform for the dissemination of cutting-edge research, innovative clinical practices, and emerging trends in cardiovascular health. Holding a respected Q2 ranking in the 2023 Scopus category for Cardiology and Cardiovascular Medicine, and positioned within the 74th percentile of its field, ANGIOLOGY is an invaluable resource for researchers, healthcare professionals, and students alike. While currently not an open-access journal, it offers subscription options to access comprehensive articles that aim to advance knowledge and improve patient care across various cardiovascular disciplines. The journal's commitment to fostering dialogue and sharing groundbreaking findings underscores its importance in the ongoing pursuit of cardiovascular excellence.

PLATELETS is a distinguished journal published by Taylor & Francis Inc that has been at the forefront of research in the fields of hematology and medicine since its inception in 1990. With an ISSN of 0953-7104 and an E-ISSN of 1369-1635, this journal boasts a solid reputation, as reflected by its Q2 ranking in both Hematology and Miscellaneous Medicine categories in 2023. PLATELETS serves as an essential platform for disseminating pioneering research, reviews, and case studies related to platelet biology, thrombosis, hemostasis, and their clinical implications. Although not an open-access publication, it is indexed in reputable databases, ensuring visibility and citation of quality contributions. Researchers, clinicians, and students alike will find valuable insights that may inform their work and enhance their understanding of the crucial role of platelets in health and disease. This journal's commitment to advancing knowledge and fostering innovation makes it a pivotal resource in the academic community.

Hamostaseologie is a prominent academic journal dedicated to the field of hematology, published by GEORG THIEME VERLAG KG. With an ISSN of 0720-9355 and an E-ISSN of 2567-5761, this journal has been at the forefront of critical research and advancements since its inception in 1981, and it continues to maintain its relevance in the scientific community with a converged publication until 2024. Ranked in the Q3 quartile in Hematology for 2023, and positioned at #44 out of 137 in the Scopus Medicine Hematology category, it represents a substantial contribution to scholarly discourse. Researchers and professionals alike will find valuable insights within its pages, as it disseminates rigorous studies and reviews that address pertinent issues related to hemostasis and coagulation. While the journal does not currently offer Open Access, readers can access its valuable content through institutional subscriptions, making it an essential resource for students, clinicians, and researchers aiming to deepen their understanding of hematological science.

American Journal of Hematology, published by Wiley, stands as a premier outlet for the dissemination of cutting-edge research in the field of hematology. With a commendable impact factor and ranked #9 out of 137 in the Scopus medicine category, this journal has established a robust presence since its inception in 1976. Operating in the Q1 quartile for hematology, it serves as a crucial resource for researchers, clinicians, and students dedicated to understanding blood disorders and advancing treatment methodologies. While the journal does not currently offer open access options, it remains highly regarded for its rigorous peer-review process and impactful contributions to the scientific community. With coverage extending into 2024, the American Journal of Hematology is committed to fostering innovation and collaboration within the hematological sciences.

EuroIntervention is a prestigious academic journal dedicated to the field of cardiology and cardiovascular medicine, published by EUROPA EDITION. Established as an essential resource for researchers and healthcare professionals, the journal holds an impressive Q1 ranking in both Cardiology and Cardiovascular Medicine as of 2023, demonstrating its influence and commitment to advancing knowledge in these fields. With an ISSN of 1774-024X and an E-ISSN of 1969-6213, EuroIntervention aims to publish high-quality research and clinical studies that address contemporary challenges in cardiovascular therapies. The journal is recognized for its rigorous peer-review process, ensuring that each article contributes valuable insights to the community. Researchers will find EuroIntervention a vital platform to disseminate their findings and engage with innovative cardiology techniques. Operating from France, the journal aspires to bridge the gap between research and clinical practice, making it an essential read for cardiologists, medical professionals, and students alike, keen to stay abreast of the latest advancements in cardiovascular care.

The Egyptian Journal of Haematology, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, stands as a pivotal resource in the field of hematology, particularly within the context of Egypt and the broader Middle Eastern region. This journal is dedicated to disseminating high-quality research that explores the latest advancements in blood disorders, hematologic malignancies, and transfusion medicine. With a focus on original research, case studies, and reviews, it aims to provide a comprehensive platform for hematologists, researchers, and healthcare professionals to enhance their understanding and management of hematological conditions. Although it is not an open-access journal, the rigorous peer-review process ensures that only the most impactful studies are published, contributing to the journal's reputation in the academic community. The Egyptian Journal of Haematology serves as an essential tool for advancing knowledge, improving clinical outcomes, and fostering collaboration among experts in the field.

Vascular Specialist International, published by the Korean Society of Vascular Surgery, serves as a pivotal platform in the field of vascular surgery and cardiovascular medicine. With an Open Access policy established since 2014, the journal encourages a broader dissemination of research findings to an international audience, fostering collaboration and innovation among researchers, clinicians, and students alike. The journal, ISSN 2288-7970, is headquartered in South Korea and spans a significant publication back to its inception, focusing on advancing clinical practice and research in vascular health. In the 2023 rankings, it is positioned in quartile Q4 for Cardiology and Cardiovascular Medicine and Q3 for Surgery, reflecting its growing impact within the scientific community. Furthermore, it holds commendable Scopus rankings in both categories, indicating its relevance and contributions to the field. With a mission to enhance vascular surgery practices and improve patient outcomes worldwide, Vascular Specialist International stands as an essential resource for those dedicated to advancing the science and art of vascular healthcare.

BLOOD REVIEWS is a highly regarded journal published by Churchill Livingstone, specializing in the fields of Hematology and Oncology. With an impressive Q1 ranking in both disciplines and placing in the top 10% of its peer categories according to Scopus metrics, it provides an essential platform for the dissemination of cutting-edge research and reviews pertaining to blood disorders and cancer treatment. Since its inception in 1987 and continuing through 2024, the journal has established itself as a cornerstone for healthcare professionals, researchers, and students who seek to advance their understanding of hematologic and oncologic topics. While not an open-access journal, BLOOD REVIEWS retains a reputation for delivering high-quality, peer-reviewed articles that foster dialogue and innovation within the scientific community. For those in the United States and beyond, the journal serves as a vital resource, housed at the Journal Production Department in Edinburgh, Scotland, ensuring accessibility and a global reach in its critical academic contributions.

Acta Phlebologica, published by EDIZIONI MINERVA MEDICA, is a pivotal journal dedicated to the field of cardiovascular medicine, specifically focusing on the complexities of venous diseases and phlebology. With an ISSN of 1593-232X and an E-ISSN of 1827-1766, this journal serves as a platform for researchers, clinicians, and students to disseminate their findings and insights relevant to venous health. While it currently holds a Q4 status in the Cardiology and Cardiovascular Medicine category, its emphasis on critical aspects of clinical practice and research aims to improve understanding and management of venous disorders. The journal, which has been in circulation since 2013, operates on a subscription basis, ensuring access to high-quality, peer-reviewed content. As the readership grows, Acta Phlebologica aspires to enrich knowledge within the cardiovascular community, fostering advancements in patient care and innovative research.